Publications by authors named "David Jarema"

Article Synopsis
  • This clinical trial aimed to improve treatment outcomes for patients with locally advanced non-small cell lung cancer (NSCLC) by using adaptive radiation therapy that tailors the treatment based on the patient's response, while minimizing side effects like lung and esophageal toxicity.
  • A total of 47 patients participated, receiving personalized radiation doses based on imaging techniques (FDG-PET and SPECT) to maximize the dose to the tumor while sparing healthy lung tissue.
  • Results showed manageable toxicity levels after one year, with 21.3% experiencing grade 2 pneumonitis and 66.0% grade 2 esophagitis, while striving for better local control and overall survival.
View Article and Find Full Text PDF

Purpose: Locally advanced lung cancer (LALC) treatment planning is often complex due to challenging tradeoffs related to large targets near organs at risk, making the judgment of plan quality difficult. The purpose of this work was to update and maintain a multi-institutional knowledge-based planning (KBP) model developed by a statewide consortium of academic and community practices for use as a plan quality assurance (QA) tool.

Methods And Materials: Sixty LALC volumetric-modulated arc therapy plans from 2021 were collected from 24 institutions.

View Article and Find Full Text PDF

Purpose: Current radiation therapy (RT) treatment planning relies mainly on pre-defined dose-based objectives and constraints to develop plans that aim to control disease while limiting damage to normal tissues during treatment. These objectives and constraints are generally population-based, in that they are developed from the aggregate response of a broad patient population to radiation. However, correlations of new biologic markers and patient-specific factors to treatment efficacy and toxicity provide the opportunity to further stratify patient populations and develop a more individualized approach to RT planning.

View Article and Find Full Text PDF

Purpose: Limits on mean lung dose (MLD) allow for individualization of radiation doses at safe levels for patients with lung tumors. However, MLD does not account for individual differences in the extent or spatial distribution of pulmonary dysfunction among patients, which leads to toxicity variability at the same MLD. We investigated dose rearrangement to minimize the radiation dose to the functional lung as assessed by perfusion single photon emission computed tomography (SPECT) and maximize the target coverage to maintain conventional normal tissue limits.

View Article and Find Full Text PDF